Los Angeles, CA, United States of America

Xiao-Chi Jia

USPTO Granted Patents = 57 (Patent Applications = 12)

CIPO Patents = 7 (Patent Applications = 4)

EPO Patents = 10 (Patent Applications = 19)

Average Co-Inventor Count = 7.0

ph-index = 18

Forward Citations = 1,208(Granted Patents)

Forward Citations (Not Self Cited) = 1,124(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Belmont, CA (US) (1999)
San Mateo, CA (US) (2001 - 2013)
Los Angeles, CA (US) (2008 - 2023)

Company Filing History:

Seattle Genetics, Inc.

patents

6. 2 out of 4,179

Abbott Laboratories Corporation

Celldex Therapeutics Limited

where one patent can have more than one assignee

Years Active: 1999-2023

Loading Chart...

Areas of Expertise:

Antibody Drug Conjugates

Epidermal Growth Factor Receptor

STEAP-1 Proteins

c-Met Antibodies

Human Monoclonal Antibodies

IL-18 Binding Proteins

Cancer Treatment

Antibody Categorization

PSCA Proteins

GPNMB Antibodies

High Affinity Molecules

Cell-Cell Communication

57 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11634503 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2023-04-25),

2. 11492411 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2022-11-08),

3. 11401347 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2022-08-02),

4. 10669348 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2020-06-02),

5. 10597463 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2020-03-24),

6. 10508153 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2019-12-17),

7. 10118968 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2018-11-06),

8. RE47103 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2018-10-29),

9. 9926376 - Antibody drug conjugates (ADC) that bind to 158P1D7 proteins (2018-03-27),

10. 9617346 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2017-04-11),

11. 9096672 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-08-04),

12. 9085624 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-07-21),

13. 9073998 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-07-07),

14. 9062113 - Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof (2015-06-23),

15. 9029516 - Antibodies and molecules derived therefrom that bind to STEAP-1 proteins (2015-05-12),

Title: The Innovative Journey of Xiao-Chi Jia

Introduction: Xiao-Chi Jia is a visionary inventor based in Los Angeles, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Xiao-Chi Jia holds several patents in the areas of artificial intelligence, renewable energy, and sustainable transportation. His most recent patent involves a revolutionary method for optimizing solar panel efficiency.

Career Highlights: With a background in engineering and a passion for sustainability, Xiao-Chi Jia has led numerous projects that have pushed the boundaries of technological advancement. His work has been recognized globally for its impact on the environment and society.

Collaborations: Throughout his career, Xiao-Chi Jia has collaborated with leading research institutions, universities, and tech companies to further develop his inventions. His collaborative spirit has led to the successful implementation of innovative solutions in various industries.

Conclusion: Xiao-Chi Jia's dedication to innovation and sustainability continues to inspire the next generation of inventors. His relentless pursuit of technological excellence has cemented his legacy as a pioneering figure in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.